Literature DB >> 23563655

Sphingolipid metabolism and atherosclerosis.

Xian-Cheng Jiang1, Jing Liu.   

Abstract

Atherosclerosis is the major cause of mortality in the developed countries. Although presently known risk factors have some predictive value for the disease, a major part of the variability in this process remains unexplained. It is extremely important to find new approaches for better understanding of the disease and for treating it. Exploration of the sphingolipid metabolism is one of these approaches. Sphingolipids are a large class of lipids with structural and signaling functions. Recent researches indicated that these lipids play important roles in the development of atherosclerosis. In this chapter, we summarized the major findings in the field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563655     DOI: 10.1007/978-3-7091-1511-4_7

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  6 in total

Review 1.  S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis.

Authors:  Anna Cantalupo; Annarita Di Lorenzo
Journal:  J Pharmacol Exp Ther       Date:  2016-06-17       Impact factor: 4.030

Review 2.  Implication of sphingosin-1-phosphate in cardiovascular regulation.

Authors:  Ningjun Li; Fan Zhang
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

3.  Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.

Authors:  Jessica S Ross; Sarah B Russo; Georgia C Chavis; Lauren A Cowart
Journal:  Clin Lipidol       Date:  2017-01-18

Review 4.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

5.  Essential Oils from Fructus A. zerumbet Protect Human Aortic Endothelial Cells from Apoptosis Induced by Ox-LDL In Vitro.

Authors:  Yan Chen; Duo Li; Yini Xu; Yanyan Zhang; Ling Tao; Shouqiao Li; Yan Jiang; Xiangchun Shen
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-23       Impact factor: 2.629

6.  Integration of Metabolomics With Pharmacodynamics to Elucidate the Anti-myocardial Ischemia Effects of Combination of Notoginseng Total Saponins and Safflower Total Flavonoids.

Authors:  Yuqing Meng; Zhiyong Du; Yan Li; Lichao Wang; Peng Gao; Xiaoyan Gao; Chun Li; Mingbo Zhao; Yong Jiang; Pengfei Tu; Xiaoyu Guo
Journal:  Front Pharmacol       Date:  2018-06-25       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.